Day 1
Mood: Cautious, steady
Medications: Buprenorphine 200 mcg, Paracetamol 1000 mg (as needed), Lamotrigine 200 mg, Nortriptyline 125 mg, Quetiapine 100 mg (lunch), 300 mg (night)
Pain present on waking, lower back stiffness. Managed through the day without major escalation. Energy moderate. Anxiety contained. Steady start.
Day 2
Mood: More strained
Medications: Buprenorphine 200 mcg, Paracetamol 1000 mg, Diazepam 10 mg, Lamotrigine 200 mg, Nortriptyline 125 mg, Quetiapine 100 mg (lunch), 300 mg (night)
Pain increased with spasm. Energy lower. Anxiety higher. More active medication use required.
Day 3
Mood: More balanced
Medications: Buprenorphine 200 mcg, Paracetamol 1000 mg (as needed), Lamotrigine 200 mg, Nortriptyline 125 mg, Quetiapine 100 mg (lunch), 300 mg (night)
Pain reduced. Energy improved in bursts. Anxiety lower. Cravings minimal.
Day 4
Mood: Variable
Medications: Buprenorphine 200 mcg, Paracetamol 1000 mg, Diazepam 10 mg, Lamotrigine 200 mg, Nortriptyline 125 mg, Quetiapine 100 mg (lunch), 300 mg (night)
Fluctuating pain and energy. Anxiety rose during difficult periods. Managed through adjustment.
Day 5
Mood: Difficult
Medications: Buprenorphine 200 mcg (additional within limits), Paracetamol 1000 mg, Diazepam 10 mg, Lamotrigine 200 mg, Nortriptyline 125 mg, Quetiapine 100 mg (lunch), 300 mg (night)
Pain more persistent. Energy low. Anxiety and fatigue increased. Higher reliance on medication.
Day 6
Mood: Slightly improved
Medications: Buprenorphine 200 mcg, Paracetamol 1000 mg (as needed), Lamotrigine 200 mg, Nortriptyline 125 mg, Quetiapine 100 mg (lunch), 300 mg (night)
Pain reduced. Energy slightly better. Anxiety lower. More controlled day.
Day 7
Mood: Steadier
Medications: Buprenorphine 200 mcg, Paracetamol 1000 mg (as needed), Lamotrigine 200 mg, Nortriptyline 125 mg, Quetiapine 100 mg (lunch), 300 mg (night)
Pain manageable. Energy moderate. Anxiety low. Stable end to week.
Reflection
The level of detail in medication use is intentional. This is not included to promote or prescribe anything, but to show the reality of what a taper like this involves. For many people, the process is reduced to a simple idea—reduce the dose, manage the symptoms, move forward. In practice, it is far more complex. Medications overlap, symptoms fluctuate, and decisions have to be made in real time about what is safe, what is necessary, and what is sustainable.
By recording the medications alongside the daily experience, it becomes clearer that this is not a passive process. It requires active management, constant awareness, and careful balancing of pain, function, sedation, and safety. It also shows that use of medication does not mean failure. Some days require more support. Some require less. Both can still be part of a successful taper.
The aim in including this level of detail is to give a more accurate picture of what the experience actually looks like—so that the struggle is visible, but also the control, the structure, and the progress. This is not about perfection. It is about showing the reality of persistence, adjustment, and continued forward movement within a difficult process.
